The U.S. Food and Drug Administration announced recently its updated drug safety recommendations for use of the drug, simvastatin (Zocor). The FDA now recommends limiting the use of the highest approved dose of the drug (simvastatin 80mg), due to the increased risk of muscle damage and muscle injury (myopathy).

In addition to the new restrictions surrounding limits on the drug’s dosage, the FDA is also requiring that changes be made to the simvastatin label, adding new contraindications and dose limitations for using the drug with certain medications.

It seems the cholesterol-lowering medication is currently the subject of the FDA’s latest drug safety communication, specifically intended to educate, inform and protect consumers. Furthermore, this recent announcement from the FDA reaches the public as a result of its ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury.

RESULTS & SETTLEMENTS

Frank M. Eidson P.A. has been tirelessly representing the rights of Central Florida victims since 1989.

$1.2 Million

Two surgeries for back injuries.

$1 Million

Fell from a roof while working.

$1.15 Million

Brain injury in a tractor-trailer crash.


Free, No Obligation Case Review.

Fill out our contact form below for your free, no obligation case review.

  • This field is for validation purposes and should be left unchanged.
Help provide wounded servicemen and women with therapeutic outdoor adventures. Like our Facebook page and we'll contribute $1 to Wounded Warriors Outdoors.

Contact Our Orlando Attorney

If you have been injured in an accident, turn to Frank M. Eidson P.A. Whether your case is a simple collision or a complicated auto wrongful death case, contact personal injury lawyer Frank Eidson today to schedule your free consultation.

407-245-2887